Product Development
and R&D

Through rigorous science and product innovation, we are dedicated to crafting better cannabis solutions for patient care.

R&D

Evidence-Based Innovation. Backed by Science.

Flora Terra's product development and research initiatives are rooted in clinical science and medical relevance.

Evidence-Based Innovation

Our team of pharmaceutical scientists, clinicians, and cannabinoid researchers continuously develops formulations that meet the highest standards of the European medical cannabis market. These standards demand not only purity and consistency, but also clear clinical rationale and reproducible efficacy.

Backed by Science

All of our product innovation is driven by global clinical studies, medical literature, and real-world patient outcomes. We actively monitor emerging research on cannabinoid pharmacology, dosage forms, and condition-specific applications—allowing us to deliver therapies informed by the latest science.

Full-Spectrum Formulation

From cannabinoid ratio customization to delivery method optimization, we offer full-spectrum as well as T-Free formulations services. Our trained specialists have helped brands and patients develop their own unique and proprietary blend of cannabinoids to fit their own unique needs.

Medical cannabis oils, capsules, tinctures, and inhalable formats
Targeted formulations for neurological, inflammatory, oncological, and pain-related conditions
Product R&D for brand clients and licensed partners
Clinical trial design collaboration and white-label development
Regulatory strategy alignment with EU medical cannabis frameworks

Evidence-Based Innovation.
Precision-Grown Therapies.

At Flora Terra, our approach to product development is built on a foundation of clinical science, global regulatory alignment, and real-world therapeutic needs. From EU-compliant dried flower varietals to complex pharmaceutical formulations, every product we develop is informed by evidence-based research, designed to meet the rigorous medical cannabis standards of the European Union, and tailored for patient safety and therapeutic efficacy.

We maintain a dynamic pipeline of products that serve licensed producers, healthcare providers, and pharmaceutical companies operating in tightly regulated medical markets.

Pharmaceutical-Grade Dried Flower

Our range of EU-GACP cultivated, EU-GMP processed dried cannabis flower is developed specifically for medical use—ensuring consistency, traceability, and purity in every batch. We offer a carefully curated selection of strains, chemovars, and cannabinoid/terpene profiles, each cultivated under precise indoor, hydroponic conditions. Our dried flower product line includes:

High-THC, balanced, and high-CBD varietals
Multiple terpene profiles suited to condition-specific applications (e.g. limonene-rich, myrcene-dominant)
Indica, sativa, and hybrid genetic lines
Flower packaged in compliance with EU pharmaceutical labeling standards
Certificate of Analysis (COA) with every batch

Each varietal in our collection undergoes rigorous internal testing and validation, including terpene fingerprinting, cannabinoid concentration control, and microbial, heavy metal, and pesticide screening.

Custom Cultivation & Client Genetics

For pharmaceutical companies, medical cannabis brands, or product developers seeking exclusive cannabinoid or terpene profiles, we offer custom cultivation services using client-supplied genetics—or strains selected through our genetic matching program. Our pheno-hunting and selection process allows us to:

Stabilize and scale your unique cultivar
Identify the most medically viable phenotypes based on potency, chemotype, morphology, and yield
Evaluate traits for EU-GACP and EU-GMP process compatibility
Conduct small-batch test grows and validation harvests before commercial rollout

We also offer IP protection protocols, traceability mapping, and collaboration with your R&D team to optimize flower expression for medical-grade outcomes.

Formulations & Innovation Beyond Flower

Our in-house pharmaceutical and clinical science team works closely with clients to develop non-combustible formats aligned with modern medical delivery standards. Based on international clinical data and patient feedback, we engineer products tailored to various therapeutic areas such as pain management, neurological disorders, inflammatory conditions, oncology support, and more. We offer full-cycle product development and production services including:

Cannabinoid ratio design and standardization
Extraction method matching (full-spectrum, broad-spectrum, isolate)
Formulation for oils, softgels, sublinguals, and inhalables
Product stability and shelf-life testing
EU regulatory dossier support and clinical trial collaboration

All Flora Terra products are developed to meet or exceed EU pharmacovigilance, labeling, and safety data standards, ensuring ease of market entry and long-term therapeutic value.

Partner with Our Science-Led Product Division

Whether you're launching a new flower line, developing specialized extracts, or need clinical-grade cannabinoid products tailored to strict medical regulations, Flora Terra offers turnkey product development grounded in science, precision, and compliance.

Explore what's possible when nature meets pharmaceutical innovation.

Get in Touch